Mereo BioPharma Group plc (AIM:MPH)
26.50
-0.50 (-1.85%)
At close: Dec 17, 2020
Mereo BioPharma Group Revenue
In the year 2025, Mereo BioPharma Group had annual revenue of $500.00K USD.
Revenue
$500.00K
Revenue Growth
n/a
P/S Ratio
112.33
Revenue / Employee
$13.89K
Employees
36
Market Cap
41.73M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 500.00K | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 10.00M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 49.37M | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ProService Building Services Marketplace | 303.19M |
| The Character Group | 100.47M |
| Sanderson Design Group | 98.16M |
| Nexteq | 67.04M |
| Steppe Cement | 66.78M |
| LendInvest | 48.60M |
| Time Finance | 37.76M |
| Calnex Solutions | 19.08M |
Mereo BioPharma Group News
- 10 hours ago - INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines - MREO - PRNewsWire
- 11 hours ago - INVESTOR ALERT: Berger Montague Advises Mereo BioPharma Group PLC (NASDAQ: MREO) Investors to Inquire About a Securities Fraud Class Action by April 6, 2026 - GlobeNewsWire
- 21 hours ago - MREO Deadline: MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit - PRNewsWire
- 1 day ago - MREO FINAL DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Mereo BioPharma Group plc Investors to Secure Counsel Before Important April 6 Deadline in Securities Class Action – MREO - GlobeNewsWire
- 1 day ago - MREO FINAL DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Mereo BioPharma Group plc Investors to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO - Newsfile Corp
- 1 day ago - MREO Investor Alert - Mereo BioPharma Group plc Investors with Large Losses Should Contact Robbins LLP for Information About the Securities Fraud Class Action Lawsuit - Business Wire
- 1 day ago - MEREO LAWSUIT DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urges Mereo BioPharma Stockholders with Large Losses to Contact the Firm Before April 6th - GlobeNewsWire
- 1 day ago - MREO INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Mereo BioPharma Investors of Securities Class Action Deadline on April 6, 2026 - Newsfile Corp